Ischemic acute renal failure (ARF) is a common clinical syndrome, asso
ciated with high morbidity and mortality, for which there is no specif
ic therapy. Polymorphonuclear neutrophils (PMN) recruited during reper
fusion have been implicated as mediators of renal parenchymal injury i
schemic ARF. Leukocyte adhesion molecules appear to facilitate PMN rec
ruitment in this setting. Complementary studies using monoclonal antib
odies, antisense oligonucleotides and gene ''knockout'' indicate that
blockade of CD11/CD18 integrins and intercellular adhesion molecule-1
(ICAM-1) attenuates ARF in some experimental models of renal ischemia.
These exciting observations may herald the development of novel anti-
adhesion strategies for use in human disease.